STEPHANIE GARRISON: Open Payments
NPI 1124094446 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 30 payments from 11 companies in 2025. Trend: 2023 $26 · 2024 $774 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 5 | $186 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $109 |
| PFIZER INC. | 4 | $69 |
| ABBVIE INC. | 3 | $53 |
| MILLICENT US INC | 3 | $50 |
| Hologic Sales and Service, LLC | 2 | $45 |
| SHIELD THERAPEUTICS INC | 1 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Organon LLC | 2 | $37 |
| Sage Therapeutics, LLC | 2 | $33 |
Products named: TWIRLA, SLYND, COMIRNATY, ACCRUFER, MYFEMBREE, NEXPLANON, FEMRING, UBRELVY.
Industry payments across OK — which companies pay providers there.
